Valuation: CStone Pharmaceuticals

Market Cap 7.71B 1.15B 1.03B 956M 870M 1.64B 111B 1.65B 11.55B 4.49B 56.53B 4.32B 4.22B 182B P/E 2026 *
-16.7x
P/E 2027 * 4.53x
Enterprise Value 6.73B 1B 896M 835M 760M 1.43B 96.71B 1.44B 10.09B 3.92B 49.36B 3.77B 3.69B 159B EV / Sales 2026 *
15.9x
EV / Sales 2027 * 2.14x
Free-Float
79.65%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+0.42%
1 week+7.99%
Current month-2.47%
1 month-16.21%
3 months+4.07%
6 months-38.20%
Current year+9.51%
1 week 0.61
Extreme 0.6104
0.66
1 month 0.55
Extreme 0.554
0.67
Current year 0.45
Extreme 0.4471
1.12
1 year 0.45
Extreme 0.4471
1.12
3 years 0.09
Extreme 0.092
1.35
5 years 0.09
Extreme 0.092
1.35
10 years 0.09
Extreme 0.092
1.98
Manager TitleAgeSince
Chief Executive Officer 62 25/08/2022
Director of Finance/CFO - 18/01/2023
Chief Operating Officer 46 01/08/2016
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 25/08/2022
Director/Board Member 63 09/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+7.99% - - 1.15B
+0.02%-3.52%+35.27%+111.11% 1,019B
-1.21%-6.99%+34.42%+60.96% 617B
+1.12%-0.20%+15.45%+80.24% 464B
-3.30%-6.15%+57.14%+34.69% 356B
+0.93%-3.16%+21.65%+43.02% 333B
+0.12%-2.77%+10.70%+32.97% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-3.62%+37.01%+52.02% 218B
-0.08%-4.98%+27.34%+93.61% 179B
Average -0.49%-3.54%+25.78%+57.40% 410.8B
Weighted average by Cap. -0.39%-3.54%+28.68%+68.60%

Financials

2026 *2027 *
Net sales 423M 63.11M 56.3M 52.46M 47.74M 89.9M 6.08B 90.56M 634M 247M 3.1B 237M 232M 9.97B 1.72B 257M 229M 213M 194M 366M 24.74B 369M 2.58B 1B 12.63B 964M 943M 40.59B
Net income -384M -57.21M -51.03M -47.55M -43.27M -81.48M -5.51B -82.09M -574M -224M -2.81B -215M -210M -9.04B 680M 101M 90.54M 84.35M 76.76M 145M 9.77B 146M 1.02B 397M 4.99B 381M 373M 16.04B
Net Debt -978M -146M -130M -121M -110M -208M -14.04B -209M -1.46B -570M -7.17B -547M -536M -23.04B -4.02B -600M -535M -499M -454M -855M -57.78B -861M -6.03B -2.34B -29.49B -2.25B -2.2B -94.8B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
147
Date Price Change
05/10/26 €0.6242 +0.42%
02/10/26 €0.6216 -2.63%
01/10/26 €0.6384 -0.25%
30/09/26 €0.6400 +4.85%
29/09/26 €0.6104 +9.71%
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.844CNY
Average target price
12.36CNY
Spread / Average Target
+155.18%

Quarterly revenue - Rate of surprise